IGF-1 Release in the Medial Prefrontal Cortex Mediates the Rapid and Sustained Antidepressant-like Actions of Ketamine
Maintaining weight loss after GLP-1 therapy is one of the most actively researched topics in obesity medicine right now
K.HoJ.RoseJ
doi: 10.3389/fnut.2025.1709867 Received 21 September 2025 Accepted 30 October 2025 Published 03 December 2025 Volume 12 - 2025 Edited by Michael Mathai, Victoria University, Australia Reviewed by Hengyi Xu, The University of Texas at Austin, United States Ting Zhang, Jilin University, China Updates Copyright 2025 Wu
Furthermore, L-carnitine can also restore anti-oxidative molecules and enzymes, such as GSH, SOD, catalase and GPX, in kidney diseases (Ye et al., 2010